A key to pregnancy-associated malaria

November 01, 2004

A malaria protein that traps infected cells in the placenta may provide a promising new target for a vaccine against pregnancy-associated malaria (PAM). Salanti and colleagues show that the malaria protein VAR2CSA is displayed on malaria-infected cells that bind to the placenta, as they report in the November 1 issue of The Journal of Experimental Medicine. This causes a dangerous infection, which puts both mother and developing child at risk.

Most adults living in malaria-endemic locations have antibodies in their circulation that protect them from repeated infection by blocking the ability of parasite-infected cells to lodge in blood vessels. But during pregnancy, placental cells display a unique molecule called CSA that is not found elsewhere. The parasite takes advantage of this by turning on a protein that can bind to CSA and that has never been seen by antibody-producing cells. The absence of blocking antibodies that bind this protein allows the parasite to slip through a loophole in an otherwise effective immune response and establish an infection. The immune cells eventually detect this new malaria protein and produce protective antibodies, which explains why PAM is mainly a risk during first-time pregnancies.

Although a family of related malaria proteins that confer the ability to bind to the placenta had been identified previously, the role of this protein has remained elusive. Salanti et al now show that another member of this protein family, VAR2CSA, is selectively produced on the surface of infected cells that can bind to the placenta. They find that women, but not men, from endemic areas have circulating antibodies that recognize this protein, and that women with high levels of VAR2CSA-specific antibody give birth to heavier babies than those with low levels. These findings suggest that these antibodies have a protective effect and provide hope that VAR2CSA-specific antibodies raised by vaccination may protect women against PAM. The researchers now hope to define a minor piece of this protein that can be used to induce blocking antibodies in women.
-end-


Journal of Experimental Medicine

Related Malaria Articles from Brightsurf:

Clocking in with malaria parasites
Discovery of a malaria parasite's internal clock could lead to new treatment strategies.

Breakthrough in malaria research
An international scientific consortium led by the cell biologists Volker Heussler from the University of Bern and Oliver Billker from the UmeƄ University in Sweden has for the first time systematically investigated the genome of the malaria parasite Plasmodium throughout its life cycle in a large-scale experiment.

Scientists close in on malaria vaccine
Scientists have taken another big step forward towards developing a vaccine that's effective against the most severe forms of malaria.

New tool in fight against malaria
Modifying a class of molecules originally developed to treat the skin disease psoriasis could lead to a new malaria drug that is effective against malaria parasites resistant to currently available drugs.

Malaria expert warns of need for malaria drug to treat severe cases in US
The US each year sees more than 1,500 cases of malaria, and currently there is limited access to an intravenously administered (IV) drug needed for the more serious cases.

Monkey malaria breakthrough offers cure for relapsing malaria
A breakthrough in monkey malaria research by two University of Otago scientists could help scientists diagnose and treat a relapsing form of human malaria.

Getting to zero malaria cases in zanzibar
New research led by the Johns Hopkins Center for Communication Programs, Ifakara Health Institute and the Zanzibar Malaria Elimination Program suggests that a better understanding of human behavior at night -- when malaria mosquitoes are biting -- could be key to preventing lingering cases.

Widely used malaria treatment to prevent malaria in pregnant women
A global team of researchers, led by a research team at the Liverpool School of Tropical Medicine (LSTM), are calling for a review of drug-based strategies used to prevent malaria infections in pregnant women, in areas where there is widespread resistance to existing antimalarial medicines.

Protection against Malaria: A matter of balance
A balanced production of pro and anti-inflammatory cytokines at two years of age protects against clinical malaria in early childhood, according to a study led by ISGlobal, an institution supported by ''la Caixa'' Foundation.

The math of malaria
A new mathematical model for malaria shows how competition between parasite strains within a human host reduces the odds of drug resistance developing in a high-transmission setting.

Read More: Malaria News and Malaria Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.